SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328874. A total of 30 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $865,000 | – | 691,651 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,727,308 | $3,437,000 | 0.14% |
| Monashee Investment Management LLC | 348,473 | $693,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 91,645 | $182,000 | 0.03% |
| Ikarian Capital, LLC | 200,000 | $398,000 | 0.02% |
| 20/20 Capital Management, Inc. | 10,000 | $29,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,400 | $43,000 | 0.00% |
| SEAVIEW INVESTMENT MANAGERS LLC | 1,221 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 337,529 | $671,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 2 | $0 | 0.00% |
| UBS Group AG | 4,207 | $9,000 | 0.00% |